B LYMPHOBLASTIC LYMPHOMA
Clinical trials for B LYMPHOBLASTIC LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new B LYMPHOBLASTIC LYMPHOMA trials appear
Sign up with your email to follow new studies for B LYMPHOBLASTIC LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy shows promise for childhood leukemia in major trial
Disease control OngoingThis large phase 3 study tests whether adding the drug blinatumomab to standard chemotherapy helps prevent cancer from returning in children and young adults with newly diagnosed B-cell leukemia or lymphoma, including those with Down syndrome. About 6,720 participants receive tre…
Matched conditions: B LYMPHOBLASTIC LYMPHOMA
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 17, 2026 03:56 UTC
-
New combo therapy shows promise for older blood cancer patients
Disease control OngoingThis study compares a new treatment that combines a targeted drug (inotuzumab) with standard chemotherapy against chemotherapy alone for older adults with B-cell acute lymphoblastic leukemia or lymphoma. The targeted drug works like a smart bomb, attaching to cancer cells and del…
Matched conditions: B LYMPHOBLASTIC LYMPHOMA
Phase: PHASE2 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Disease control
Last updated May 14, 2026 12:04 UTC